首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1729260

2025-2033年日本肝素市場報告（依產品、來源、給藥方式、應用、最終用戶、配銷通路和地區）

Japan Heparin Market Report by Product, Source, Mode of Administration, Application, End User, Distribution Channel, and Region 2025-2033

出版日期: 2025年05月01日 | 出版商:

IMARC | 英文 121 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2024 年日本肝素市場規模達 3.375 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 6.09 億美元，2025-2033 年期間的成長率 (CAGR) 為 6.27%。需要抗凝血治療的心血管疾病（如深部靜脈栓塞、肺栓塞）、心房顫動等病例的增加正在推動市場的發展。

肝素是一種廣泛使用的抗凝血藥物，有助於防止循環系統中血栓的產生。它是一種天然存在的物質，存在於動物的肝臟和肥大細胞中，特別是肺和腸的黏膜。肝素透過抑制凝血酶和其他凝血因子的活性來發揮作用，阻止纖維蛋白原轉化為纖維蛋白，這是血塊形成的關鍵步驟。肝素透過靜脈或皮下注射給藥，常用於各種醫療環境，包括手術、透析以及治療肺栓塞和深部靜脈栓塞等疾病。它被認為是一種速效抗凝血劑，常用於緊急情況下預防危及生命的血栓。然而，其使用需要仔細監測以避免過度出血，並且患者可能需要頻繁地進行血液檢查以調整劑量。

日本肝素市場趨勢：

許多關鍵因素正在推動日本肝素市場的成長。首先，該地區人口老化導致對肝素治療的需求增加，因為老年人更容易罹患深部靜脈栓塞和肺栓塞等疾病。此外，心血管疾病和癌症等慢性疾病病例的增加也增加了對肝素等抗凝血治療的需求。此外，抗凝血劑在治療重症病例中的重要性日益增加，也為市場帶來了積極的前景。此外，製藥業正在進行的研發工作正在產生肝素的新配方和輸送方法，從而提高其有效性和安全性。監管機構還透過執行嚴格的品質標準和安全法規在推動市場方面發揮關鍵作用，這激發了醫療保健專業人員和患者的信心。此外，人們對肝素益處的認知不斷提高，以及肝素在新興市場的日益普及，正在推動市場擴張。最後，醫療技術和外科手術的許多進步擴大了肝素的應用範圍，促進了其在各種醫療環境中的採用，預計將在未來幾年推動日本肝素市場的發展。

日本肝素市場細分：

產品洞察：

普通肝素
低分子量肝素（LMWH）
超低分子量肝素（ULMWH）

來源洞察：

管理模式洞察：

口服
腸外

應用程式洞察：

心房顫動和心臟病發作
中風
深部靜脈血栓（DVT）
肺栓塞（PE）
其他

最終用戶洞察：

醫院
診所
家庭護理設置
門診手術中心
其他

配銷通路洞察：

醫院藥房
零售藥局
藥局
網路商店
其他

競爭格局：

市場研究報告也對競爭格局進行了全面的分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀表板和公司評估象限等競爭分析。此外，也提供了所有主要公司的詳細資料。

本報告回答的關鍵問題：

日本肝素市場目前表現如何？未來幾年將如何表現？
COVID-19對日本肝素市場有何影響？
日本肝素市場依產品分類是怎麼樣的？
日本肝素市場依來源分類是怎麼樣的？
根據管理模式，日本肝素市場是如何分類的？
日本肝素市場依應用分類的狀況如何？
根據最終用戶，日本肝素市場是如何分佈的？
日本肝素市場依照配銷通路的分佈是怎樣的？
日本肝素市場的價值鏈分為哪些階段？
日本肝素鈉的主要促進因素和挑戰是什麼？
日本肝素市場的結構是怎麼樣的？主要參與者是誰？
日本肝素市場競爭程度如何？

本報告回答的關鍵問題：

日本肝素市場目前表現如何？未來幾年將如何表現？
COVID-19對日本肝素市場有何影響？
日本肝素市場依產品分類是怎麼樣的？
日本肝素市場依來源分類是怎麼樣的？
根據管理模式，日本肝素市場是如何分類的？
日本肝素市場依應用分類的狀況如何？
根據最終用戶，日本肝素市場是如何分佈的？
日本肝素市場依照配銷通路的分佈是怎樣的？
日本肝素市場的價值鏈分為哪些階段？
日本肝素鈉的主要促進因素和挑戰是什麼？
日本肝素市場的結構是怎麼樣的？主要參與者是誰？
日本肝素市場競爭程度如何？

Japan heparin market size reached USD 337.5 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 609.0 Million by 2033, exhibiting a growth rate (CAGR) of 6.27% during 2025-2033. The increasing cases of cardiovascular diseases such as deep vein thrombosis, pulmonary embolism, atrial fibrillation, etc., that require anticoagulant therapy, are driving the market.

Heparin is a widely used anticoagulant medication that helps in preventing the production of blood clots in the circulatory system. It is a naturally occurring substance found in the liver and mast cells of animals, particularly in the mucous membranes of the lungs and intestines. Heparin works by inhibiting the activity of thrombin and other clotting factors, thereby preventing the conversion of fibrinogen into fibrin, a crucial step in blood clot formation. Heparin is administered through intravenous or subcutaneous injection and is commonly employed in various medical settings, including surgeries, dialysis, and as a treatment for ailments, such as pulmonary embolism and deep vein thrombosis. It is considered a fast-acting anticoagulant and is often used in emergency situations to prevent life-threatening clots. However, its use requires careful monitoring to avoid excessive bleeding, and patients may need frequent blood tests to adjust the dosage.

Japan Heparin Market Trends:

Numerous key factors are driving the growth of the heparin market in Japan. Firstly, an aging regional population is contributing to increased demand for heparin-based therapies, as older individuals are more susceptible to conditions like deep vein thrombosis and pulmonary embolism. Additionally, the rising cases of chronic diseases such as cardiovascular disorders and cancer are bolstering the need for anticoagulant treatments like heparin. Furthermore, the rising importance of anticoagulants in managing severe cases is also creating a positive outlook for the market. Moreover, the pharmaceutical industry's ongoing R&D efforts are yielding novel formulations and delivery methods for heparin, enhancing its effectiveness and safety profile. Regulatory agencies are also playing a pivotal role in driving the market by enforcing stringent quality standards and safety regulations, which inspire confidence among healthcare professionals and patients alike. Furthermore, the escalating awareness about the benefits of heparin and its growing availability in emerging markets are fueling market expansion. Lastly, numerous advancements in medical technology and surgical procedures, which have expanded the applications of heparin, promoting its adoption in various medical settings, are expected to drive the heparin market in Japan in the coming years.

Japan Heparin Market Segmentation:

Product Insights:

Unfractionated Heparin
Low Molecular Weight Heparin (LMWH)
Ultra-Low Molecular Weight Heparin (ULMWH)

Source Insights:

Bovine
Porcine

Mode of Administration Insights:

Oral
Parenteral

Application Insights:

Atrial Fibrillation and Heart Attack
Stroke
Deep Vein Thrombosis (DVT)
Pulmonary Embolism (PE)
Others

End User Insights:

Hospitals
Clinics
Homecare Settings
Ambulatory Surgical Centers
Others

Distribution Channel Insights:

Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Stores
Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan heparin market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan heparin market?
What is the breakup of the Japan heparin market on the basis of product?
What is the breakup of the Japan heparin market on the basis of source?
What is the breakup of the Japan heparin market on the basis of mode of administration?
What is the breakup of the Japan heparin market on the basis of application?
What is the breakup of the Japan heparin market on the basis of end user?
What is the breakup of the Japan heparin market on the basis of distribution channel?
What are the various stages in the value chain of the Japan heparin market?
What are the key driving factors and challenges in the Japan heparin?
What is the structure of the Japan heparin market and who are the key players?
What is the degree of competition in the Japan heparin market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Heparin Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Heparin Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Heparin Market - Breakup by Product

6.1 Unfractionated Heparin
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 Low Molecular Weight Heparin (LMWH)
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
6.3 Ultra-Low Molecular Weight Heparin (ULMWH)
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2019-2024)
- 6.3.3 Market Forecast (2025-2033)

7 Japan Heparin Market - Breakup by Source

7.1 Bovine
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 Porcine
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)

8 Japan Heparin Market - Breakup by Mode of Administration

8.1 Oral
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Parenteral
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)

9 Japan Heparin Market - Breakup by Application

9.1 Atrial Fibrillation and Heart Attack
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2019-2024)
- 9.1.3 Market Forecast (2025-2033)
9.2 Stroke
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2019-2024)
- 9.2.3 Market Forecast (2025-2033)
9.3 Deep Vein Thrombosis (DVT)
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2019-2024)
- 9.3.3 Market Forecast (2025-2033)
9.4 Pulmonary Embolism (PE)
- 9.4.1 Overview
- 9.4.2 Historical and Current Market Trends (2019-2024)
- 9.4.3 Market Forecast (2025-2033)
9.5 Others
- 9.5.1 Historical and Current Market Trends (2019-2024)
- 9.5.2 Market Forecast (2025-2033)

10 Japan Heparin Market - Breakup by End User

10.1 Hospitals
- 10.1.1 Overview
- 10.1.2 Historical and Current Market Trends (2019-2024)
- 10.1.3 Market Forecast (2025-2033)
10.2 Clinics
- 10.2.1 Overview
- 10.2.2 Historical and Current Market Trends (2019-2024)
- 10.2.3 Market Forecast (2025-2033)
10.3 Homecare Settings
- 10.3.1 Overview
- 10.3.2 Historical and Current Market Trends (2019-2024)
- 10.3.3 Market Forecast (2025-2033)
10.4 Ambulatory Surgical Centers
- 10.4.1 Overview
- 10.4.2 Historical and Current Market Trends (2019-2024)
- 10.4.3 Market Forecast (2025-2033)
10.5 Others
- 10.5.1 Historical and Current Market Trends (2019-2024)
- 10.5.2 Market Forecast (2025-2033)

11 Japan Heparin Market - Breakup by Distribution Channel

11.1 Hospital Pharmacies
- 11.1.1 Overview
- 11.1.2 Historical and Current Market Trends (2019-2024)
- 11.1.3 Market Forecast (2025-2033)
11.2 Retail Pharmacies
- 11.2.1 Overview
- 11.2.2 Historical and Current Market Trends (2019-2024)
- 11.2.3 Market Forecast (2025-2033)
11.3 Drug Stores
- 11.3.1 Overview
- 11.3.2 Historical and Current Market Trends (2019-2024)
- 11.3.3 Market Forecast (2025-2033)
11.4 Online Stores
- 11.4.1 Overview
- 11.4.2 Historical and Current Market Trends (2019-2024)
- 11.4.3 Market Forecast (2025-2033)
11.5 Others
- 11.5.1 Historical and Current Market Trends (2019-2024)
- 11.5.2 Market Forecast (2025-2033)

12 Japan Heparin Market - Competitive Landscape

12.1 Overview
12.2 Market Structure
12.3 Market Player Positioning
12.4 Top Winning Strategies
12.5 Competitive Dashboard
12.6 Company Evaluation Quadrant

13 Profiles of Key Players

13.1 Company A
- 13.1.1 Business Overview
- 13.1.2 Product Portfolio
- 13.1.3 Business Strategies
- 13.1.4 SWOT Analysis
- 13.1.5 Major News and Events
13.2 Company B
- 13.2.1 Business Overview
- 13.2.2 Product Portfolio
- 13.2.3 Business Strategies
- 13.2.4 SWOT Analysis
- 13.2.5 Major News and Events
13.3 Company C
- 13.3.1 Business Overview
- 13.3.2 Product Portfolio
- 13.3.3 Business Strategies
- 13.3.4 SWOT Analysis
- 13.3.5 Major News and Events
13.4 Company D
- 13.4.1 Business Overview
- 13.4.2 Product Portfolio
- 13.4.3 Business Strategies
- 13.4.4 SWOT Analysis
- 13.4.5 Major News and Events
13.5 Company E
- 13.5.1 Business Overview
- 13.5.2 Product Portfolio
- 13.5.3 Business Strategies
- 13.5.4 SWOT Analysis
- 13.5.5 Major News and Events

14 Japan Heparin Market - Industry Analysis

14.1 Drivers, Restraints and Opportunities
- 14.1.1 Overview
- 14.1.2 Drivers
- 14.1.3 Restraints
- 14.1.4 Opportunities
14.2 Porters Five Forces Analysis
- 14.2.1 Overview
- 14.2.2 Bargaining Power of Buyers
- 14.2.3 Bargaining Power of Suppliers
- 14.2.4 Degree of Competition
- 14.2.5 Threat of New Entrants
- 14.2.6 Threat of Substitutes
14.3 Value Chain Analysis